Scientific Literature
Articles on Biothera compounds that were published in peer-reviewed science and medical journals:
March 2008
Mobilization of Hematopoietic Progenitor Cells by Yeast-derived ß-Glucan Requires Activation of Matrix Metalloproteinase-9.
Stem Cells published online Mar 13, 2008; DOI: 10.1634/stemcells. 2007-0712.
February 2008
Clinical Cancer Research 2008;1239 14(4) February 15, 2008.
September 2007
Toxicological Assessment of a Particulate Yeast (1,3)-ß-D-Glucan in Rats.
Food and Chemical Toxicology. (2007), doi:10.1016/j.fct.2007.03.013.
Cancer Research. 2007 67: 7421-7430.
December 2006
β-Glucan is a Fungal Determinant for Adhesion-Dependent Human Neutrophil Functions.
The Journal of Immunology. Dec 2006; 177: 8667 - 8675.
August 2006
Yeast β-Glucan Amplifies Phagocyte Killing of iC3b-opsonized Tumor Cells via CR3-Syk-PI3-kinase Pathway.
The Journal of Immunology. 2006 Aug 1;177(3):1661-9
April 2006
The Effect of PGG-Beta-Glucan on Neutrophil Chemotaxis in Vivo.
Journal of Leukocyte Biology. 2006 Apr; 79 (4:667-75). Epub 2006 Jan 13.
January 2006
Beta-Glucan Enhances Complemented-Mediated Hematopoietic Recovery after Bone Marrow Injury.
Blood. 15 January 2006. Volume 107, Number 2.
June 2005
C5a-Mediated Leukotriene B4-Amplified Neutrophil Chemotaxis is Essential in Tumor Immunotherapy Facilitated by Anti-Tumor Monoclonal Antibody and ß-Glucan.
The Journal of Immunology. 2005 174:7050-7056.
May 2005
Yeast Whole Glucan Particle ß-Glucan in Conjunction with Anti-tumour Monoclonal Antibodies to Treat Cancer.
Expert Opinion on Biological Therapy. May 2005, Vol. 5, No. 5, Pages 691-702.
September 2004
ß-Glucan Affects Leukocyte Navigation in a Complex
Chemotactic Gradient.
Surgery. 2004: 136:384-89.
July 2004
Mechanism by Which Orally Administered ß-1,3-Glucans Enhance
the Tumorcidial Activity of AntiTumor Monoclonal Antibodies
in Murine Tumor Models.
The Journal of Immunology. 2004: 173: 797-806.
March 2004
Complement Function in Monoclonal Antibody-Mediated Cancer Immunotherapy.
Review published in Trends in Immunology.
December 2003
ß-Glucan Functions as an Adjuvant for Monoclonal Antibody Immunotherapy by Recruiting Tumoricidal Granulocytes as Killer Cells.
Cancer Research. 63, 9023-9031, Dec. 15, 2003.
March 2003
Anthrax-Protective Effects of Yeast Beta 1,3 Glucans.
Medscape General Medicine.
May 2002
Pilot Study: Orally-Administered Yeast ß1,3-glucan Prophylactically Protects Against Anthrax Infection and Cancer in Mice.
The Journal of the American Nutraceutical Association.
Vol. 5, No. 2, Spring 2002.